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Abstract
The prolactin (PRL) and growth hormone (GH) gene families represent species-specific expansions
of pregnancy-associated hormones/cytokines. In this review we examine the structure, expression
patterns, and biological actions of the pregnancy-specific PRL and GH families.
Review
Prolactin (PRL) and growth hormone (GH) are hor-
mones/cytokines responsible for the coordination of a
wide range of biological processes in vertebrates. They can
act as classic endocrine modulators (hormones) via entry
into the circulation or locally (cytokines) through juxta-
crine, paracrine and autocrine modes of action. In the
mouse, rat, and cow and likely other mammalian species
there are large families of paralogous genes closely related
to PRL [1-4]. The human and rhesus monkey genomes
and likely other primate genomes possess a single PRL
family gene, but unlike the rat and mouse contain an
expanded GH gene family [2,3]. Sheep and goat genomes
each contain duplicated GH loci [5,6]. Members of the
PRL family of genes have been given a variety of names,
including placental lactogens (PLs), PRL-like proteins
(PLPs), PRL-related proteins (PRPs), proliferin (PLF), and
PLF-related protein (PLF-RP), whereas, members of the
GH family are referred to as PLs, GH variant (GH-V), and
chorionic somatomammotropins [1-3]. Unfortunately, in
some instances the literature contains nomenclature that
is confusing. PRL and GH family ligands are expressed in
cell- and temporal-specific patterns in the anterior pitui-
tary and uteroplacental compartment [1-3,7-9]. An over-
riding theme characteristic of the PRL and GH families is
their association with pregnancy and regulatory mecha-
nisms controlling viviparity. In this minireview we exam-
ine the structure, expression patterns, and biological
actions of the PRL and GH families from rodents (prima-
rily rat and mouse), ruminants (primarily ovine and
bovine), and primates (primarily human).
Species-specific gene family expansion
The annotation of genes from genome sequencing
projects has provided considerable insight into the exist-
ence of species-specific gene expansion. Although the
biology of most of these expanded gene families is not
well understood, the majority appear to be associated
with reproduction and host defense [10]. Gene families
arise by gene duplication and natural selection [11]. PRL
gene families of rodents and ruminants and the GH gene
family of primates represent excellent examples of species-
specific gene expansion. While the mouse and rat PRL
families are largely orthologous, the expanded bovine PRL
family is not orthologous with rodent PRL families, which
suggests the independent utilization of the ancestral PRL
template [12]. Primates have utilized an evolutionarily
related template (ancestral GH) [2], while genomes for
other mammalian species may not possess either an
expanded PRL or GH family [13]. The overall breadth of
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our understanding of the diversity of PRL and GH families
is both modest and biased because of the few species
investigated.
Structural features
PRL and GH genes are structurally similar and evolved
from a common ancestral precursor. Lists of PRL and GH
family members from the mouse and rat, bovine and
ovine, and human and rhesus monkey are provided in
Tables 1,2 and 3. The PRL family genes in the mouse and
rat are clustered on chromosomes 13 [4] and 17 [14],
respectively. To date at least 26 separate mouse genes
encoding members of the PRL family have been localized
within a one-megabase segment [4]. The alignment of
genes along the mouse PRL family locus primarily reflects
sequence conservation. Commonalities in cell-specific
and/or temporal-specific aspects of gene expression do
not appear to be main factors governing alignment within
the locus. The solitary GH genes are situated on chromo-
somes 11 and 10 of the mouse and rat genomes, respec-
tively [15,16]. Eight identified PRL family members from
the cow are located on chromosome 23 [17]. An
expanded five-member GH gene cluster spans approxi-
mately 48 kb on chromosome 17 of the human genome,
whereas the sole human PRL gene is present on chromo-
some 6 [2]. Members of the human GH family are closely
related structural variants, whereas members of the rat,
mouse, and bovine PRL families exhibit considerable
sequence diversity.
Table 1: Members of the mouse and rat PRL and GH gene families
Member Abbreviation Mouse GenBank Accession No. Rat GenBank Accession No.
Prolactin family members*
Prolactin PRL NM_011164 NM_012629
Placental lactogen-Iα PL-Iα AF525162 D21103
Placental lactogen-Iβ PL-Iβ NM_172155 ---
Placental lactogen-Iγ PL-Iγ NM_172156 ---
Placental lactogen-I variant PL-Iv --- NM_033233
Placental lactogen-II PL-II M14647 M13749
Proliferin-1 PLF-1 NM_031191 ---
Proliferin-2 PLF-2 K03235 ---
Proliferin-3 PLF-3 NM_011954 ---
Proliferin-4 PLF-4 AF128884 ---
Proliferin-related protein PLF-RP NM_011120 NM_053364
Prolactin-like protein-A PLP-A NM_011165 NM_017036
Prolactin-like protein-B PLP-B NM_011166 M31155
Prolactin-like protein-C PLP-C --- NM_173110
Prolactin-like protein-C variant PLP-Cv --- NM_020079
Prolactin-like protein-Cα PLP-Cα NM_011167 ---
Prolactin-like protein-Cβ PLP-Cβ NM_023332 NM_134385
Prolactin-like protein-Cγ PLP-Cγ NM_023741 ---
Prolactin-like protein-Cδ PLP-Cδ NM_028477 ---
Prolactin-like protein-D PLP-D --- NM_022537
Prolactin-like protein-H PLP-H --- NM_021580
Decidual prolactin-related protein DPRP NM_010088 NM_022846
Prolactin-like protein-E PLP-E NM_008930 ---
Prolactin-like protein-F PLP-F NM_011168 NM_022530
Prolactin-like protein-I PLP-I AF525154 NM_153736
Prolactin-like protein-J PLP-J NM_013766 NM_031316
Prolactin-like protein-K PLP-K NM_025532 NM_138861
Prolactin-like protein-L PLP-L NM_023746 NM_138527
Prolactin-like protein-M PLP-M NM_019991 NM_053791
Prolactin-like protein-N PLP-N AF525156 NM_153738
Prolactin-like protein-O PLP-O NM_026206 ---
Growth hormone family member
Growth hormone GH NM_008117 V01237
*Please note that additional candidate rat PRL family genes have been identified from the rat genome project, which have not yet been investigated.Reproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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Two primary exon-intron arrangements are evident: i) a
prototypical five exon-four intron structure notable for
both PRL and GH and many other members of the PRL
and GH families and ii) a six exon-five intron structure
present in members of the rodent PLP-C subfamily
[2,4,7]. The latter exon/intron arrangement has been
identified in both the rat and mouse and represents the
addition of a short exon between exons II and III of the
prototypical PRL or GH exon/intron organization. The
mouse PLP-E gene is related to the latter subgroup but is
unusual in that it has a seven exon-six intron structure,
with two short exons situated between the prototypical
exons II and III [4]. Each of the human GH family tran-
scripts can undergo alternative processing [2]. The human
PRL gene has two physically separated promoters, which
are responsible for tissue-specific expression [18]. The
extent of alternative promoter usage or post-transcrip-
tional processing of PRL/GH family transcripts in other
species is not well appreciated.
Translation products generated from the PRL and GH
family transcripts exhibit sequence conservation, similari-
ties in the positioning of cysteines, and likely conforma-
tion. All proteins are synthesized with a signal peptide of
approximately 30 amino acids and are targeted for secre-
tion. Many of the mature proteins receive post-transla-
tional addition of carbohydrates. Glycosylation patterns
are cell type- and protein-dependent and may influence
the bioavailability and/or biological activities of the pro-
teins [19]. The three-dimensional structure for members
of the PRL and GH families is predicted to be composed
of a four-helix bundle connected in a unique "up-up-
down-down" arrangement [20]. This structural arrange-
ment facilitates interactions of PRL and GH with their
receptors and their activation of intracellular signaling
pathways. It is assumed that the natural variants of PRL
and GH possess similar structures; however, it is not
known how these structural features impact their biologi-
cal activities.
Table 2: Members of the bovine and ovine PRL and GH gene families
Member Abbreviation Bovine GenBank Accession No. Ovine GenBank Accession No.
Prolactin family members*
Prolactin PRL V00112 M27057
Placental lactogen PL NM_181007 M31660
Prolactin related protein-I PRP-I NM_174159 ---
Prolactin related protein-II PRP-II M27239 ---
Prolactin related protein-III PRP-III NM_174160 ---
Prolactin related protein-IV PRP-IV M33269 ---
Prolactin related protein-V PRP-V X15975 ---
Prolactin related protein-VI PRP-VI X59504 ---
Growth hormone family members
Growth hormone GH NM_180996 AH005460
Growth hormone2-Z GH2-Z --- AH005492
*Please note that the list of bovine and ovine PRL family members is probably not complete. Additional bovine PRL family members and possibly 
ovine PRL members may be discovered as bovine and ovine genome projects move forward.
Table 3: Members of the primate PRL and GH gene families
Member Abbreviation Human GenBank Accession No. Rhesus Monkey GenBank Accession No.
Prolactin family member
Prolactin PRL NM_000948 U09018
Growth hormone family members*
Growth hormone-N GH-N NM_000515 L16556
Chorionic somatomammotropin-L CS-L, rhCS3 NM_001318 L16554
Chorionic somatomammotropin-A CS-A, rhCS1 NM_001317 L16552
Growth hormone variant GH-V NM_002059 U02293
Chorionic somatomammotropin-B CS-B, rhCS2 NM_020991 L16553
*Please note that it is difficult to precisely assign orthologs for the human and rhesus monkey CS genes and that multiple transcripts have been 
identified for each human GH family member. GenBank accession numbers are only presented for transcript variant 1.Reproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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Expression patterns
Members of the PRL and GH families of cytokines are pro-
duced in the anterior pituitary and at the maternal-fetal
interface (Fig. 1). In mammalian species the anterior pitu-
itary produces both PRL and GH. Somatotrophs, lac-
totrophs and somatolactotrophs of the anterior pituitary
are important sources of both PRL and GH [21]. Anterior
pituitary synthesis and secretion of PRL and GH are
responsive to the integration of neural and endocrine sig-
nals. These two hormones, their sites of synthesis in the
anterior pituitary, and their regulation are highly con-
served across mammalian species. This degree of conser-
vation is not as evident for members of the PRL and GH
families expressed at the maternal-fetal interface. Decid-
ual cells of primates and rodents produce members of the
PRL family, as do rodent and ruminant trophoblast cells,
while, primate and ovine trophoblast cells express mem-
bers of the GH gene family (Fig. 1).
Uterus
During pregnancy, differentiated uterine stromal cells in
primates and rodents are referred to as decidual cells and
are prominent sources of PRL family gene expression
[22,23]. Cellular events during decidual cell formation, a
process referred to as decidualization; include prolifera-
tion and differentiation of uterine stromal cells. Decidual
tissue effectively provides a barrier between the develop-
ing embryo and the remainder of the uterus. The control
of decidualization differs in primates and rodents. Forma-
tion of decidual cells in primates is progesterone-depend-
ent and occurs during the luteal phase of each menstrual
cycle. Decidualization in the mouse and rat is similarly
progesterone-dependent but also requires activatory sig-
nals provided by the implanting blastocyst [24]. In
rodents, these events begin at the site of implantation
within the antimesometrial endometrium (farthest from
the incoming blood supply). Mesometrial and antimes-
ometrial decidua are morphologically and functionally
distinct. In primates, PRL, the sole member of the primate
PRL family, is expressed in the uterine decidua [23,25]. As
introduced above, lactotroph- and decidual cell-specific
PRL expression are under the control of two physically
separated promoters situated within the 5' flanking region
of the prolactin gene and are responsive to distinct regula-
tory signals [18,23]. PRL of decidual origin is also glyco-
sylated differently than is PRL from the anterior pituitary,
which may contribute to distinct biological actions [26].
In rodents (mouse and rat), decidual cells localized
within the antimesometrial uterine compartment express
at least four members of the PRL family [decidual PRP,
PLP-B, PLP-J, and PRL; [27-30]]. The regional expression
pattern of the rodent decidual PRL family ligands is likely
a key to ultimately understanding their physiology during
the establishment of pregnancy.
Trophoblast cells
Trophoblast cells arise through the differentiation of a
multilineage pathway and show elements of species spe-
cificity in their development and organization into pla-
cental structures. Rodents and primates possess a
hemochorial placenta, an invasive form of placentation
characterized by maternal blood directly bathing tro-
phoblast cells; whereas ruminants possess a synepithelial-
chorial placenta, with minimal invasion and maximal
cellular separation between maternal and fetal compart-
ments [31,32]. Nutrient delivery is histiotrophic, via
maternal uterine gland secretions, and/or hemotrophic,
via the maternal blood [31,33-35]. Histiotrophic nutri-
tion occurs throughout pregnancy in ruminants and dur-
ing early phases of gestation in rodents and primates.
Hemotrophic nutrition predominates following estab-
lishment of the hemochorial placenta.
Rodents
Three regions within the mature mouse and rat uteropla-
cental site possess trophoblast cells: the labyrinth zone,
the junctional zone, and the uterine mesometrial com-
partment [Fig. 2]. PRL family members are expressed in
cell type-, location-, and temporal-specific profiles [36]. In
rodents, three different trophoblast cell lineages are capa-
ble of expressing members of the PRL family: trophoblast
giant cells, spongiotrophoblast cells, and invasive tro-
phoblast cells [3,4,37,38]. Each cell type expresses a
unique subset of PRL family members. Locations of hor-
mone/cytokine production influence post-translational
processing and temporal and spatial access to biological
targets. Trophoblast giant cells form the early interface
with the maternal environment. Once the chorioallantoic
placenta is established trophoblast giant cells localize to
the junctional zone and during the last week of gestation
this same cell type arises within the labyrinth zone. The
labyrinth zone of the chorioallantoic placenta is princi-
pally involved in bidirectional nutrient/waste transport
between maternal and fetal compartments, functions
assumed by syncytial trophoblast cells [39]. The transient
development of trophoblast giant cells within the laby-
rinth zone may facilitate hormone/cytokine delivery into
the fetal compartment. Transcriptional control of tro-
phoblast giant cell-specific gene expression has been
investigated using the Rcho-1 trophoblast cell line
[41,42]. Spongiotrophoblast cells arise just prior to midg-
estation, are prominent cellular constituents of the junc-
tional zone, and a major source of most PRL family
members throughout the latter half of gestation. Secretory
products of spongiotrophoblast cells are particularly
abundant in maternal circulation. An in vitro cell culture
system for studying spongiotrophoblast cell expression of
PRL family members has been established [42]. During
the last week of gestation, a population of trophoblast
cells exits the chorioallantoic placenta. These invasive tro-Reproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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phoblast cells are more prominent in the rat where they
invade deep into the uterine mesometrial compartment
forming intimate relationships with spiral arteries, pro-
ducing a unique subset of PRL family members [37,38].
The invasive trophoblast cells have first access to blood-
borne nutrients, toxic compounds, signaling molecules,
and cells entering the uterine environment. In vitro sys-
tems for investigating invasive trophoblast cells have not
been described. The two remaining lineages of rodent tro-
phoblast cells, glycogen cells and syncytial trophoblast
cells, do not express members of the rodent PRL family.
However, mouse syncytial trophoblast cells, which share
transport properties with human syncytial trophoblast
cells, do possess the transcriptional machinery needed to
activate transgenic DNA constructs containing the locus
control region of the human GH gene family [43]. The
conservation suggests an interesting analogous relation-
ship between syncytial trophoblast cells of humans and
rodents. Promoter regions for the mouse and rat PL-II
genes have been identified that direct placental-specific
expression in transgenic mice [14,44-46]. At least one
member of the PRL family has been shown to exhibit
allele-specific expression patterns. These experiments
were performed in deer mice, Peromyscus [47]. Peromyscus
PL-Iv expression is restricted to the paternal allele and to
spongiotrophoblast cells of the chorioallantoic placenta.
Interestingly, spongiotrophoblast cell development is reg-
ulated by a maternally imprinted transcription factor,
Mash2 [48], and is abnormally affected by disruptions in
genomic imprinting, as seen in placentas from cloned
Sources of PRL and GH family cytokines in rat and mouse, human, ovine, and bovine species Figure 1
Sources of PRL and GH family cytokines in rat and mouse, human, ovine, and bovine species. Abbreviations: PRL, 
prolactin; GH, growth hormone.
Rat/Mouse
GH
Anterior
Pituitary Decidua
Trophoblast
Trophoblast giant cell
Spongiotrophoblast
Invasive trophoblast
PRL Family
Human
GH Family
Anterior
Pituitary Decidua
Trophoblast
Syncytial trophoblast
Extravillous trophoblast
PRL
Ovine
GH Family
Anterior
Pituitary
Trophoblast
Binucleate cell
Binucleate-endometrial
heterokaryon
PRL Family
Bovine
GH
Anterior
Pituitary
Trophoblast
Binucleate cell
Binucleate-endometrial 
heterokaryon
PRL FamilyReproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
Page 6 of 15
(page number not for citation purposes)
mice [49] and following interspecies breeding [50,51]. At
present, it is not known whether genomic imprinting is a
feature shared among other members of the Peromyscus
PRL family or between PRL and GH family loci from other
species; nor is the biological significance of the allele-spe-
cific expression pattern appreciated.
Ruminants
Three trophoblast cell types are associated with placenta-
tion in ruminants: i) uninucleate trophoblast cells, ii)
binucleate trophoblast cells, and iii) heterokaryons
formed by the fusion of binucleate trophoblast cells with
endometrial epithelial cells. Uninucleate trophoblast cells
serve as precursors for binucleate cell formation. Binucle-
ate trophoblast cells and trophoblast-endometrial heter-
okaryons of sheep and cattle produce PLs [1,52]. PRP-I
shows a similar expression pattern in the bovine placenta
[53]. Expression of PLs and PRP-I begins around the time
of the initial embryo-uterine interactions [1,7,53]. The
cellular localization and ontogeny of placental expression
for other members of the bovine PRL family have not
been reported. Ovine placental GH is expressed in each of
the above cell populations during a restricted period of
gestation (days 35 to 70), and is controlled by mecha-
nisms distinct from the regulation of GH production by
the anterior pituitary [6]. A new bovine trophoblast cell
A schematic representation of a late gestation rat uteroplacental compartment Figure 2
A schematic representation of a late gestation rat uteroplacental compartment. Please note that trophoblast cells 
located in the uterine mesometrial compartment, junctional zone, and labyrinth zone all contribute to the production of PRL 
family ligands.Reproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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differentiation culture system capable of binucleate cell
formation and PL synthesis offers great promise for future
in vitro analyses of PRL and GH family gene expression
[54,55].
Primates
Transcripts for members of the GH family (GH-V, CS-A,
CS-B, and CS-L) have each been detected in the human
placenta [2,23]. CS-A and CS-B genes encode for identical
mature secreted proteins, collectively referred to as CS,
and are regulated similarly [2,23]. Although, CS-L tran-
scripts have been identified, they likely contribute to low
levels of translated products [2]. Two principal trophob-
lastic structures exist within the human placenta: villous
and extravillous trophoblast cells. Syncytial trophoblast
cells of the villous portion of the chorioallantoic placenta
are a major source of GH family members, as are extravil-
lous invasive trophoblast [2,23,56]. The latter cell popula-
tion is analogous with the invasive trophoblast of the
rodent placenta and merits additional investigation
regarding their expression of GH family cytokines. Tran-
scription of GH family genes is regulated by a locus con-
trol region located 23 kb upstream of the cluster [43,57].
Four members of the rhesus monkey GH family (CS-1,
CS-2, CS-3, and GH-V), possessing extensive homology
with human GH family members, are expressed in the
monkey chorioallantoic placenta [58].
Other sites
There is some evidence for the activation or reactivation of
PRL and GH family members in a variety of tissues, espe-
cially those exhibiting pathology. Local PRL production
has been detected in the reproductive tract, mammary tis-
sue, immune cells, brain, and skin [21]; GH and GH-V
biosynthesis have been demonstrated in hematopoietic
lineages [2,6]; and CS transcripts detected in the testis
[59]. In the mouse, PLF can be expressed in tissues under-
going angiogenesis, such as wounds and tumors [60,61],
and thrombocytopenia activates PLP-E expression in
hematopoietic tissues (bone marrow and spleen; [62].
Such findings are not surprising since the targets that these
cytokines act on during the establishment of pregnancy
(see below) may also be relevant in diseased tissues.
Hormone/cytokine delivery and tissue distribution
A number of members of the PRL and GH family are
present in maternal circulation and a few members have
been detected in the fetus, presumably acting as classic
hormones [6,8,23,52,63,64]. Ligand access and availabil-
ity to target cells can be influenced by post-translational
modifications, interactions with circulating binding pro-
teins, and/or association with extracellular matrices. Addi-
tion of carbohydrate influences clearance rates of rodent
PLs [63,65]. Circulating proteins such as the extracellular
domain of the GH receptor (GH-R) and α2-macroglobulin
bind members of the PRL and GH cytokine families [66-
68]. Some members of the PRL family appear to be
restricted in their distribution because of interactions with
the extracellular matrix. Decidual PRP and human PRL
bind to heparin containing molecules and accumulate in
the decidual extracellular matrix [69-71]. Such a location
is ideal for gaining access to cells that traverse the decidua
(e.g. inflammatory and trophoblast cells) and in limiting
cytokine exposure to extrauterine sites. A few members of
the PRL and GH families have been reported to enter the
fetal circulation, whereas others are selectively excluded
from the fetus [63,64,72-76]. Human CS gains entry into
the fetal circulation, while GH-V is excluded [23].
Although GH-V is secreted into the maternal circulation of
the human, ovine placental GH has a more restricted
sphere of influence within the uteroplacental compart-
ment and fetus [6]. The decidual source of ligands may
also facilitate their entry into amniotic fluid and ulti-
mately the fetus [23]. Temporal profiles of secretion into
maternal and fetal compartments are not equivalent and
can vary during the course of pregnancy within a species
and among species. For example, in sheep, concentrations
of PL in maternal circulation attain relatively high levels
and progressively increase as gestation proceeds, whereas
fetal concentrations are considerably lower and peak at
midgestation [73]. PL concentrations in the cow show a
similar profile in the fetus but, in contrast to sheep, are
low in maternal circulation throughout gestation [72].
Our current information about hormone delivery and
transport within maternal and fetal compartments is lim-
ited to only a few examples and thus provides us with only
glimpse of what to expect.
Biological actions
Biology of the PRL and GH families of cytokines can be
subdivided into two broad categories: i) classical and ii)
nonclassical. Classical actions correspond to biological
effects mediated through interactions with PRL and/or
GH receptors (Fig. 3). Nonclassical actions reflect all other
mechanisms of ligand-mediated biological activities.
Classical actions
Ligand-receptor systems contributing to classical actions
exhibit species differences. In some species, the PRL recep-
tor (PRL-R) is the target of ligands produced at the mater-
nal-fetal interface, while in other species, hormones/
cytokines are produced that activate both PRL and GH
receptors.
Rodents
The mammary gland and corpus luteum represent two
classic biological targets of a subset of the PRL family [77-
83]. The physiological responses of these targets to PRL
family members are mediated by PRL-Rs. Ligands activat-
ing PRL-Rs during pregnancy arise from maternal (lac-Reproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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totroph and decidual: PRL), trophoblast (PL-Is, PL-Iv, PL-
II), and fetal (lactotroph: PRL) tissues (Fig. 3). Production
of these ligands is orchestrated in a precise temporal pat-
tern that ensures the presence of activators of the PRL-R
signaling system throughout gestation [3,63,84-86] (Fig.
4). The PRL-R agonists stimulate mammary epithelial cell
growth and differentiation and help maintain corpus
luteum integrity and progesterone and relaxin biosynthe-
sis. Phenotypes of PRL-/- and PRL-R-/- null mutant mouse
models support the importance of the PRL-R signaling
pathway in mammary gland and luteal biology [87].
Investigations using gene-targeting approaches are inher-
ently more complex for studying the biology of the multi-
ple PL genes expressed in trophoblast cells. In addition to
the mammary gland and corpus luteum, evidence has
arisen for PRL and the PLs modulating pregnancy-
dependent changes in brain function, pancreas biology,
and the immune system [88-92]. Local production of PRL
by decidual cells may also contribute to decidual cell sur-
vival [93,94]. The existence of multiple ligands activating
the PRL-R signaling pathway provides for complementa-
rity and specialization in ligand regulation, availability,
and possibly action [87].
Insights into intracellular events subsequent to PRL-R acti-
vation by members of the placental PRL family are mini-
mal. It is assumed that PLs activate signal transduction
pathways downstream of the PRL-R similar to those acti-
vated by PRL. Beyond the abilities of members of the PL-I
subfamily to stimulate the Jak-Signal Transducer and Acti-
vator of Transcription (STAT) pathway in Nb2 lymphoma
cells [95,96] and cultured luteinized granulosa cells [80],
information on intracellular signaling pathways triggered
by classical members of the placental PRL family is lack-
ing. It seems likely that at least some aspects of PRL sign-
aling are mimicked by PLs; however, whether these
uteroplacental ligands reproduce the full spectrum of PRL
action or elicit unique responses is unknown. The
autocrine/paracrine actions of PRL within the decidua
appear to be mediated by activation of classic PRL ligand-
PRL-R signal transduction, including stimulation of Jak2-
STAT5 and phosphatidylinositol 3-kinase/Akt signaling
pathways [93,94].
Ruminants
PLs have been postulated to affect maternal (corpus
luteum function, uterine gland development, intermedi-
ary metabolism, and mammary gland development) and
fetal physiological processes [7]. The general implication
is that PLs contribute to normal physiological adjust-
ments occurring during pregnancy; promoting corpus
luteum function, uterine and mammary gland develop-
ment, and facilitating nutrient delivery and utilization by
the fetus. These predictions have not always been sup-
ported by empirical observation. The absence of support-
ive evidence may at times be attributed to experimental
design or may instead reflect a more subtle and poten-
tially unique role of PLs in the biology of pregnancy (see
below). Some of the most impressive physiological data
relates to the local actions of PLs on uterine histiotrophic
Classical ligand-receptor relationships in rat and mouse, ovine and bovine, and human species Figure 3
Classical ligand-receptor relationships in rat and mouse, ovine and bovine, and human species. Arrows denote 
stimulatory actions; lines without arrows reflect inhibitory actions. Abbreviations: PRL, prolactin; PL-Is, placental lactogen-Iα, 
β, γ, and PL-I variant; PL-II, placental lactogen-II; GH, growth hormone; PL, placental lactogen; CSs, chorionic somatomammo-
tropins; GH-V, growth hormone variant; PRL-R, PRL receptor; GH-R, GH receptor; PRL-R/GH-R, PRL-R and GH-R 
heterodimer.
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nutrient delivery, which is of paramount importance in
ruminants [34]. PL binds to endometrial gland epithelia
and is capable of increasing uterine gland density and
uterine milk protein expression [97,98]. These in vivo
actions of PL are dependent upon the hormonal milieu
and require exposure to progesterone and interferon tau.
Ovine placental GH likely contributes to the pregnancy-
dependent functional changes in uterine gland function
[97,98] and may also influence fetal tissues prior to the
ontogeny of fetal GH production. A point of
consideration is warranted regarding comparisons of the
biology of PLs in sheep and cattle. Ovine and bovine PLs
have undergone significant sequence divergence, espe-
cially when compared to the minimal divergence for their
respective PRLs and GHs [99]. These structural changes
have contributed to some differences in regulation and
bioavailability and potentially in activities of the PLs from
each species.
Ruminant PLs offer a unique mode of action. It has been
long known that PLs of ruminants interact with both PRL
and GH receptors [7,9,52]. Early evidence suggested that
ruminant PLs were dual-acting agonists for both PRL-R
and GH-R signaling pathways and there was some sugges-
tion of a unique receptor system for ruminant PLs. Many
of these early experiments were performed with receptors
isolated from non-ruminant species. It is now known that
ruminant PLs effectively signal through PRL-R homodim-
A schematic representation of lactogenic hormone profiles during pregnancy in the mouse or rat Figure 4
A schematic representation of lactogenic hormone profiles during pregnancy in the mouse or rat. Early preg-
nancy is dominated by the twice-daily surges of PRL produced by the maternal anterior pituitary; midgestation by the products 
of three PL-I genes; and the second half of gestation by PL-II. The fetal anterior pituitary begins producing PRL at the end of 
pregnancy. Abbreviations: PRL, prolactin, PL-Is, placental lactogen-Iα, β, γ; PL-II, placental lactogen-II.Reproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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ers, PRL-R/GH-R heterodimers, and in the absence of PRL-
R may act as a GH-R antagonist [[9]; Fig. 3]. Some of the
GH-like effects of PLs may be mediated by their interac-
tion with PRL-R/GH-R heterodimers. Ruminant PLs
activate Jak/STAT and mitogen activated protein kinase
(MAPK) signaling pathways [7,9,100]. The nature of PL
signal transduction appears to differ depending upon
whether PRL-R homodimers or PRL-R/GH-R heterodim-
ers are activated. Ligand-receptor heterodimer interaction
results in prolonged STAT3 activation, which may culmi-
nate in distinct cellular responses [100]. Existence of a
separate ruminant PL receptor remains elusive. At this
juncture, ovine placental GH is thought to act via mecha-
nisms identical to GH produced by the anterior pituitary
[6,7].
Primates
Classical PRL-R and GH-R mediated actions in primates
include those stimulated by decidual PRL and placental
members of the GH family. Human decidual PRL may
accumulate in the decidual extracellular matrix due to its
association with heparin containing molecules [69] and
its targets include, intrauterine (e.g. modulatory effects on
uterine gland development and function, angiogenesis,
trophoblast cell development and function, and immune
regulation), amniotic, and possibly fetal tissues [23,25].
There is an intriguing parallel between the intrauterine
effects of decidual PRL and those of ruminant PLs on his-
tiotrophic nutrient delivery. Similarly, CSs and GH-V have
been implicated in the modulation of maternal
physiology and directly or indirectly as regulators of fetal
growth and development, as suggested for ruminant PLs
[7,23].
Genetic deletions impacting CS and GH-V have been
described and offer insight into the biology of members of
the placental GH family [2,23,101-103]. In several
instances the deficiencies of CS and GH-V had no demon-
strable impact on the progression of pregnancy [101,102];
however, a patient with CS and GH-V deficiencies exhib-
iting pregnancy-associated pathologies (including preec-
lampsia and intrauterine growth restriction) has been
described [103]. Pathologies in the latter clinical presenta-
tion may or may not be related to the absence of CS and
GH-V proteins. Although, the anecdotal nature of the clin-
ical findings makes it difficult to make absolute conclu-
sions about the biology of the placental GH family, they
suggest that the CS and GH-V genes may be dispensable in
some pregnancies.
The basis for much of the speculation concerning CS and
GH-V biology relates to their close structural similarity
with pituitary-derived GH (GH-N) and the nature of their
interactions with PRL and GH receptors [2,7,23]. Unlike
rodent and ruminant GHs, primate GH-Ns function as
potent agonists for both PRL-R and GH-R signaling. In
comparison to GH-N, CSs are equipotent activators of
PRL-R signaling and weak GH-R agonists, whereas GH-V
is a more potent GH-R agonist, and a less potent PRL-R
agonist. Introduction of these subtle functional variants
into maternal and fetal circulation during pregnancy
would seem to be an effective means of modulating PRL-
R and GH-R activation and thus maternal and fetal physi-
ology. Based on PRL-R and GH-R expression profiles, PRL-
or CS-activated PRL-R signaling is probably more signifi-
cant in the fetus than is GH-R signaling. Some evidence
exists for a unique CS receptor present in human fetal tis-
sues; however, the molecular structure of the receptor has
not been reported [23]. Signaling via PRL-R/GH-R het-
erodimers has not been described for members of the pri-
mate GH family but would seem to be a means of
expanding the diversity of signals emanating from the lig-
ands. PRL-R and GH-R signal transduction cascades acti-
vated by PRL and GH family ligands arising at the
maternal-fetal interface have not been extensively investi-
gated but are likely similar to those activated by anterior
pituitary-derived PRL and GH and involve the Jak/STAT
pathway among other signaling pathways.
Nonclassical actions
All members of the PRL family do not utilize the PRL
receptor-signaling pathway. Distinct targets and biologi-
cal actions are evident and are collectively referred to as
nonclassical. The nonclassical ligands are generated as the
primary products of individual genes and as post-transla-
tional products of PRL.
Much of our knowledge of nonclassical ligands arising as
primary products of individual genes has been garnered
from experimentation with the mouse and rat. Within the
mouse PRL family locus five genes encode for PRL-R ago-
nists. These include the PRL gene, three PL-I genes, and a
PL-II gene. Evidence for PRL-R usage by protein products
of the remaining 21 genes is not available. Some have not
been examined but others do not utilize the PRL receptor.
Cellular targets for nonclassical members of the PRL fam-
ily are intriguing in that each is known to undergo pro-
found adjustments during the course of pregnancy. They
include endothelial cells, erythrocyte and megakaryocyte
precursors, natural killer cells, eosinophils and hepato-
cytes (Table 4). PLF and PLF-RP target endothelial cells
and have agonist and antagonist effects on angiogenesis,
respectively [3,104]. PLF may also be involved in coordi-
nating responses to tissue injury [60]. Increased maternal
demands for erythrocytes and platelets are stimulated
through the actions of PLP-E and PLP-F [105-107], while
PLP-A modulates the behavior of uterine natural killer
cells, a specialized cell population contributing to mater-
nal immune responses and uteroplacental vascular
remodeling [108,109]. Specific interactions have beenReproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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identified for decidual PRP with eosinophils [71] and for
PLP-C and PLP-N with hepatocytes [S. Ohboshi, J. Busta-
mante, M.J. Soares, unpublished results]. The biological
responses of these targets to the ligands have not been
reported. Other PRL family ligands (rat PLP-B, PLP-D, and
PLP-H; bovine PRP-I) do not activate the PRL-R signaling
pathway; however, their physiological targets have not
been identified [68,110,111]. As is true, for classical mem-
bers, the overall physiological significance of nonclassical
members of the PRL family is yet to be determined.
Insights into the mechanism of action of nonclassical PRL
family members are fragmentary. PLF effects on endothe-
lial cells appear to be mediated by the insulin-like growth
factor II/mannose 6-phosphate receptor and involve G
proteins regulating MAPK activity [112,113]. These
actions appear to require a mannose 6-phosphate modifi-
cation to PLF. In contrast, even though receptors for PLF-
RP and PLP-E have not been identified, some insights into
the signaling pathways affected by the ligands have been
determined. PLF-RP inhibits angiogenesis by inhibiting
arachidonic acid release [114], while PLP-E stimulates
hematopoiesis through signal transduction cascades
involving the gp130 co-receptor and Jak/STAT pathways
[105,106]. The heparin-binding capacity of human decid-
ual PRL and rat decidual PRP may modulate their ligand-
receptor interactions, as well as those for other heparin-
binding ligands.
PRL can be proteolytically processed into an N-terminal
16 kDa species possessing novel nonclassical actions
[87,115]. 16 kDa PRL targets endothelial cells and is a
potent angiostatic factor. PRL cleavage can occur at its site
of synthesis or at its target tissues and may be mediated by
cathepsin D. The 16 kDA PRL proteolytic cleavage product
does not interact with the PRL-R. The receptor transducing
the angiostatic actions of 16 kDa PRL has not been
identified but its association with 16 kDa PRL leads to an
inhibition of the MAPK signaling pathway [87,115]. As
stated above, PLF-RP is also angiostatic but it is unclear
whether 16 kDA PRL and PLF-RP share a common recep-
tor and mechanism of action. Generation of the 16 kDa
PRL at the maternal-fetal interface and its involvement in
controlling uteroplacental vascular remodeling has not
been determined. Nonetheless, some have hypothesized
that excessive decidual production of 16 kDa PRL may
lead to preeclampsia, a pregnancy disorder associated
with defective uteroplacental vascular remodeling [116].
It is logical that other members of the PRL and GH fami-
lies might be susceptible to similar proteolytic processing.
At this time, naturally occurring truncations of other PRL
and GH family ligands have not been described.
Conclusions
A few final observations regarding the biology of the PRL
and GH families may be helpful.
For the purposes of this presentation, discussions about
classical and nonclassical biological actions were segre-
gated; however, this distinction for a ligand need not be
mutually exclusive. It is certainly possible that some PRL
or GH family ligands might be capable of activating both
classical and nonclassical pathways. Post-transcriptional
or post-translational processing may lead to the genera-
tion of ligands with expanded signaling capabilities.
Under some circumstances ligand families and their cor-
responding receptor families have undergone coordinate
evolution [11]. At first analysis, this does not seem to be
the case for the PRL and GH families. There is no evidence
for expanded PRL-R or GH-R gene families. Thus,
expanded receptor systems must have been achieved by
other means. These may include: i) post-transcriptional
and/or post-translational processing of the PRL-R and
GH-R resulting in an expansion of ligand specificities and
downstream signaling events; ii) the use of the PRL or GH
family ligands as backbones for other receptor activators,
such as carbohydrates; iii) utilization of distinct classes of
receptor signaling molecules. Evidence for the latter spec-
ulation is seen in the insulin family, where some family
Table 4: Nonclassical targets for members of the PRL family
Biological Targets Ligands (function) References
Endothelial cells PLF (angiogenic)
PLF-RP (anti-angiogenic)
16kDa-PRL (anti-angiogenic)
104, 112–115
Hematopoietic precursors PLP-E and PLP-F (promote erythrocyte and 
megakaryocyte development)
105–107
Natural killer cells PLP-A (modulator of the uterine natural killer cell 
phenotype)
108, 109
Eosinophils Decidual PRP (unknown) 71
Hepatocytes PLP-C, PLP-N (unknown) S. Ohboshi, J. Bustamante, M.J. Soares, 
unpublished resultsReproductive Biology and Endocrinology 2004, 2:51 http://www.rbej.com/content/2/1/51
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members use receptor tyrosine kinases and others use G
protein-coupled receptors [117]. The difficulty is that we
are not aware of the selective pressures that drove the
expansion of PRL and GH families of ligands. These evo-
lutionary forces presumably led to meaningful advantages
for the survival of each species. This discussion also makes
the assumption that all members of the PRL and GH fam-
ilies act as ligands, which still remains to be proven.
Research on the biology of the pregnancy-associated PRL
and GH families is laden with experiments questioning
their physiological significance. This is best illustrated by
data, cited above, that pregnancies can proceed in the
absence of CSs and GH-V in humans [2,23,101-103]. Pre-
liminary findings in the mouse suggest that null muta-
tions of individual uteroplacental PRL family genes may
also be compatible with uneventful pregnancies (R. Ain,
G. Dai, A. Godwin, M.J. Soares, unpublished results).
Such observations may seem to be in conflict with evolu-
tionary dogma. Why would the PRL and GH family gene
expansions be retained if they were not advantageous to
the organism? Some insight may be obtained from ideas
presented by Kaplan and Grumbach over two decades ago
[118]. They proposed that CSs serve as regulatory mole-
cules ensuring adaptation to physiological stressors, espe-
cially those creating increased metabolic demands.
Dorshkind and Horseman [92] have similarly advanced
the proposal that PRL is a key regulatory molecule
involved in immune system adaptations to stress. The
selective pressures driving the PRL and GH family expan-
sions did not occur in the laboratory or with the availabil-
ity of a reliable food supply and modern medical care.
Consequently, the true biology of the PRL and GH fami-
lies may only become apparent when the organisms are
presented with environmental challenges. The nature of
the challenges may differ depending upon the niche the
species occupies. Maybe such logic also helps explain why
there is considerable diversity among rodent, ruminant,
and primate PRL and GH families.
Finally, the limited species conservation violates a popu-
lar tenet of modern biomedical research and has driven
talented scientists from this important field. Understand-
ing the physiology of the PRL and GH families will pro-
vide access to important regulatory processes of
pregnancy. In some instances, cross species similarities
may prevail, while in other cases the differences may be
most compelling. Nonetheless, our appreciation for the
biology of pregnancy increases.
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